<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18786">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862327</url>
  </required_header>
  <id_info>
    <org_study_id>P/2015/275</org_study_id>
    <nct_id>NCT02862327</nct_id>
  </id_info>
  <brief_title>Intravenous Dexamethasone for Ropivacaine Axillary Block</brief_title>
  <acronym>ADEXA</acronym>
  <official_title>Intravenous Dexamethasone Versus Placebo for Ultrasound Guided Axillary Brachial Plexus Block With Ropivacaine: Randomised, Controlled, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged
      postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after
      ultrasound guided axillary brachial plexus block
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia duration after axillary brachial plexus block</measure>
    <time_frame>time to first pain at surgical site, an average of 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor block duration after axillary brachial plexus block Safety</measure>
    <time_frame>up to block recovery, an average of 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory block duration after axillary brachial plexus block</measure>
    <time_frame>up to block recovery, an average of 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse event</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Anesthesia</condition>
  <condition>Forearm Injuries</condition>
  <arm_group>
    <arm_group_label>intravenous dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intravenous injection of 8mg (2ml) of dexamethasone during regional anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intravenous injection of 2ml of NaCl 0.9% during regional anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous dexamethasone</intervention_name>
    <description>intravenous injection of dexamethasone</description>
    <arm_group_label>intravenous dexamethasone</arm_group_label>
    <other_name>DEXAMETHASONE MYLAN code UCD 9223084 3400892230849</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous placebo</intervention_name>
    <description>intravenous injection of placebo</description>
    <arm_group_label>intravenous placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>perineural ropivacaine</intervention_name>
    <description>brachial plexus block with perineural injection of Ropivacaine in the axillary fossa</description>
    <arm_group_label>intravenous dexamethasone</arm_group_label>
    <arm_group_label>intravenous placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ultrasound guidance</intervention_name>
    <description>ultrasound guidance for brachial plexus block in the axillary fossa</description>
    <arm_group_label>intravenous dexamethasone</arm_group_label>
    <arm_group_label>intravenous placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1,2 et 3

          -  surgery under axillary brachial plexus block

          -  aged &gt;18 years

          -  signed information consent

        Exclusion Criteria:

          -  impaired coagulation

          -  contraindication to regional anesthesia or technical impossibility

          -  opioids or pain killers abuse or addiction

          -  steroids consumption in the past 6 months

          -  dementia or under administrative supervision

          -  delay of surgery to short to allow regional anesthesia

          -  pregnancy and breastfeeding

          -  allergy and contraindication to dexamethasone or ropivacaine

          -  anticipated bad observation of treatment

          -  patient enrolled in another trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fancis Berthier, PH</last_name>
    <email>f1berthier@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Besancon</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie DEPIERRE</last_name>
      <phone>381218745</phone>
      <phone_ext>33</phone_ext>
      <email>sdepierre@chu-besancon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 14, 2016</lastchanged_date>
  <firstreceived_date>July 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anaesthetic techniques</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>brachial plexus block</keyword>
  <keyword>Local Anesthetic</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>analgesia</keyword>
  <keyword>steroid</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>placebo</keyword>
  <keyword>adjuvant</keyword>
  <keyword>ultrasound guided</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Forearm Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
